References

Recent advances in meningioma immunogenetics

10.3389/fonc.2019.01472 · 2019 · External reference

The 2016 World Health Organization classification of tumors of the central nervous system: a summary

10.1007/s00401-016-1545-1 · 2016 · External reference

Meningioma genomics: diagnostic, prognostic, and therapeutic applications

2016 · External reference

Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions

2021 · External reference

Epidemiology and etiology of meningioma

10.1007/s11060-010-0386-3 · 2010 · External reference

Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype

10.1093/neuonc/not325 · 2014 · External reference

Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988

1998 · External reference

Circulating tumor biomarkers in meningiomas reveal a signature of equilibrium between tumor growth and immune modulation

10.3389/fonc.2019.01031 · 2019 · External reference

Meningioma recurrence

10.1515/med-2016-0032 · 2016 · External reference

Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment

10.21037/jgo.2016.11.15 · 2017 · External reference

Methods of protein detection in cancer for diagnosis, prognosis and therapy

10.5772/intechopen.101050 · 2022 · External reference

The prognostic role of Ki-67/MIB-1 in meningioma: a systematic review with meta-analysis

10.1097/md.0000000000018644 · 2020 · External reference

Biomarkers for differentiating grade II meningiomas from grade I: a systematic review

10.1080/02688697.2021.1940853 · 2021 · External reference

Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression

10.3109/02688697.2010.522743 · 2011 · External reference

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features

10.1136/jnnp.2007.121582 · 2008 · External reference

Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas

10.1309/hxunag34b3cefdu8 · 2007 · External reference

Mitotic index is an independent predictor of recurrence-free survival in meningioma

10.1111/bpa.12174 · 2015 · External reference

Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas

10.1053/hupa.2001.27119 · 2001 · External reference

Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma

10.1002/cncr.10351 · 2002 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

10.1186/s13643-021-01626-4 · 2021 · External reference

Assessing bias in studies of prognostic factors

10.7326/0003-4819-158-4-201302190-00009 · 2013 · External reference

Unresolved reference

External reference

Biological and demographic profile of meningiomas in a cohort of egyptian patients: impact on tumor recurrence

10.1155/2013/375139 · 2013 · External reference

The immunohistochemical loss of H3K27me3 in intracranial meningiomas predicts shorter progression-free survival after stereotactic radiosurgery

10.3390/cancers14071718 · 2022 · External reference

Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma

10.1080/01616412.2021.2022915 · 2022 · External reference

Polycystin-2 Associates With Malignancy in Meningiomas

10.1097/pai.0000000000001113 · 2023 · External reference

p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk

10.1007/s11060-014-1706-9 · 2015 · External reference

Caveolin-1 in meningiomas: expression and clinico-pathological correlations

10.1007/s00401-006-0097-1 · 2006 · External reference

Brain invasion in otherwise benign meningiomas does not predict tumor recurrence

10.1007/s00401-016-1598-1 · 2016 · External reference

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort

10.1093/neuonc/noaa303 · 2021 · External reference

The prognostic role of the immunohistochemical expression of S100 in meningiomas

10.1007/s00432-022-04186-9 · 2023 · External reference

Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma

10.1111/j.1440-1789.2007.00750.x · 2007 · External reference

Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas

2017 · External reference

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

10.1371/journal.pone.0217340 · 2019 · External reference

World Health Organization grade II meningioma: A 10-year retrospective study for recurrence and prognostic factor assessment

10.1016/j.wneu.2016.01.055 · 2016 · External reference

Atypical meningioma. A study on recurrence and disease-specific survival

10.1016/j.neuchi.2017.03.004 · 2017 · External reference

Novel postoperative serum biomarkers in atypical meningiomas: A multicenter study

10.1227/neu.0000000000002457 · 2023 · External reference

Establishment and validation of an integrated model to predict postoperative recurrence in patients with atypical meningioma

2021 · External reference

Prognostic value of Ki-67 labeling index and postoperative radiotherapy in WHO grade II meningioma

10.1097/coc.0000000000000224 · 2018 · External reference

WHO grade I meningiomas that show regrowth after gamma knife radiosurgery often show 1p36 loss

10.1038/s41598-021-95956-x · 2021 · External reference

A practical predictor of the growth potential of benign meningiomas: Hypointensity of surface layer in T2-weighted magnetic resonance imaging

10.1016/j.clinimag.2020.01.009 · 2020 · External reference

Dissecting stemness in aggressive intracranial meningiomas: prognostic role of SOX2 expression

10.3390/ijms231911690 · 2022 · External reference

A study of prognostic factors in 45 cases of atypical meningioma

10.1007/s00701-016-2900-7 · 2016 · External reference

A high MCM6 proliferative index in atypical meningioma Is associated with shorter progression free and overall survivals

10.3390/cancers15020535 · 2023 · External reference

Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia

10.1002/path.4916 · 2017 · External reference

Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: a multicenter retrospective study

10.1093/jnen/nlaa038 · 2020 · External reference

Karyopherin a2 and chromosome region maintenance protein 1 expression in meningiomas: novel biomarkers for recurrence and malignant progression

10.1007/s11060-014-1423-4 · 2014 · External reference

Expression of p40 (ΔNp63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role

10.1007/s11060-016-2205-y · 2016 · External reference

EGFR soluble isoforms and their transcripts are expressed in meningiomas

10.1371/journal.pone.0037204 · 2012 · External reference

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

10.1007/s11060-016-2256-0 · 2016 · External reference

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas

10.1046/j.1365-2990.1998.00150.x · 1998 · External reference

Loss of H3K27me3 expression enriches in recurrent grade 1 & 2 meningiomas and maintains as a biomarker stratifying progression risk

10.1007/s11060-022-04169-3 · 2023 · External reference

Long-term outcomes of multimodality management for parasagittal meningiomas

10.1007/s11060-020-03440-9 · 2020 · External reference

Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution

10.3171/2017.2.jns162566 · 2017 · External reference

Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation

10.1227/neu.0b013e3182567886 · 2012 · External reference

A study of UbcH10 expression and its association with recurrence of meningiomas

10.1002/jso.22141 · 2012 · External reference

The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma

10.1016/j.humpath.2021.06.005 · 2021 · External reference

Primary resected meningiomas: relapses and proliferation markers

2004 · External reference

Microvascularization of grade I meningiomas: effect on tumor volume, blood loss, and patient outcome

10.3171/2016.10.jns161825 · 2018 · External reference

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

10.1007/s00401-018-1844-9 · 2018 · External reference

Decreased expression of LASS2 is associated with worse prognosis in meningiomas

10.1007/s11060-014-1441-2 · 2014 · External reference

Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas

10.3171/2016.11.jns16913 · 2018 · External reference

Radiosurgery for atypical and anaplastic meningiomas: histopathological predictors of local tumor control

10.1159/000338253 · 2012 · External reference

Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas

10.3171/2014.7.jns132661 · 2014 · External reference

Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters

10.1007/s00428-006-0285-3 · 2006 · External reference

Atypical meningiomas: recurrence, reoperation, and radiotherapy

10.1016/j.wneu.2015.04.033 · 2015 · External reference

Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival

10.1046/j.1365-2559.2003.01712.x · 2003 · External reference

DNA topoisomerase II-α and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases

10.5858/2002-126-1079-dtiaca · 2002 · External reference

Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome

10.1002/ijc.11013 · 2003 · External reference

WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma

10.1016/j.prp.2014.11.002 · 2015 · External reference

Higher expression of beclin 1 in human meningiomas is related to better clinical outcome and pathological grade

10.1111/apm.12995 · 2019 · External reference

Clinical features of clear cell meningioma: a retrospective study of 36 cases among 10,529 patients in a single institution

10.1007/s00701-015-2635-x · 2016 · External reference

Endothelial cell hypertrophy and microvascular proliferation in meningiomas are correlated with higher histological grade and shorter progression-free survival

10.1093/jnen/nlw095 · 2016 · External reference

STMN1 as a candidate gene associated with atypical meningioma progression

10.1016/j.clineuro.2017.06.003 · 2017 · External reference

High expression of Sp1 is associated with recurrence of meningioma

10.1016/j.wneu.2021.01.016 · 2021 · External reference

Clinical and histopathological predictors of outcome in malignant meningioma

10.1007/s10143-019-01093-5 · 2020 · External reference

Benign meningiomas (WHO grade I) with atypical histological features: correlation of histopathological features with clinical outcomes

10.3171/2015.1.jns142228 · 2016 · External reference

Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas

10.1007/s004010050458 · 1996 · External reference

The Ki-67 proliferation index as a marker of time to recurrence in intracranial meningioma

10.1093/neuros/nyaa226 · 2020 · External reference

Heat shock factor 1 in brain tumors: a link with transient receptor potential channels TRPV1 and TRPA1

10.1007/s10735-021-10025-x · 2021 · External reference

Prognostic significance of cyclin A expression in meningiomas

10.1097/00129039-200303000-00002 · 2003 · External reference

Recurrence and regrowth of benign meningiomas

10.1007/s10014-009-0251-2 · 2009 · External reference

Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index

2009 · External reference

Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence

10.1016/j.jocn.2016.02.021 · 2016 · External reference

Loss of H3K27me3 in meningiomas

10.1093/neuonc/noab036 · 2021 · External reference

Resected WHO grade I meningioma and predictors of local control

10.1007/s11060-020-03688-1 · 2021 · External reference

Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas

10.3171/2010.11.jns10701 · 2011 · External reference

Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma

10.1007/s00401-017-1678-x · 2017 · External reference

Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas

10.3171/2012.3.jns111945 · 2012 · External reference

Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression

10.1038/s41598-018-19308-y · 2018 · External reference

Phosphoproteomic and kinomic signature of clinically aggressive grade I (1.5) meningiomas reveals RB1 signaling as a novel mediator and biomarker

10.1158/1078-0432.ccr-18-0641 · 2020 · External reference

Regrowth factors of WHO grade I skull base meningiomas following incomplete resection

10.3171/2022.3.jns2299 · 2022 · External reference

The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas

10.1002/(sici)1097-0142(19980601)82:11<2262::aid-cncr23>3.0.co;2-r · 1998 · External reference

Role of her-2/neu overexpression and clinical features at presentation as predictive factors in meningiomas

10.1097/01.coc.0000128724.63600.c7 · 2004 · External reference

Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of WHO grade I intracranial meningiomas compared to WHO grade II

10.1016/j.jocn.2021.01.009 · 2021 · External reference

Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection

10.3171/2022.9.jns221530 · 2022 · External reference

The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases

10.1007/s00701-003-0173-4 · 2004 · External reference

Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas—prognostic biomarkers for routine practice

10.5114/fn.2020.96970 · 2020 · External reference

Chromosome 1p36 loss and COX-2 overexpression predict recurrence-free survival in completely removed meningioma grade I and II

2013 · External reference

Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center

10.1097/md.0000000000007385 · 2017 · External reference

The preferred locations of meningioma according to different biological characteristics based on Voxel-Wise analysis

2020 · External reference

Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications

10.1111/bpa.12884 · 2020 · External reference

Nrf2 expressions correlate with WHO grades in gliomas and meningiomas

2016 · External reference

Applying DDX3X biomarker to discriminate atypical from benign meningiomas in tissue microarray

10.1097/pai.0000000000000422 · 2018 · External reference

Meningiomas display a specific immunoexpression pattern in a rostrocaudal gradient: an analysis of 366 patients

10.1016/j.wneu.2018.11.201 · 2019 · External reference

Genomic markers of recurrence risk in atypical meningioma following gross total resection

2023 · External reference

Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients

10.1227/neu.0b013e3181eb95b7 · 2010 · External reference

AKT2 expression in histopathologic grading and recurrence of meningiomas

10.1016/j.ejso.2014.02.243 · 2014 · External reference

Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases

10.3171/2012.7.peds12179 · 2012 · External reference

Intracranial papillary meningioma: a clinicopathologic study of 30 cases at a single institution

10.1227/neu.0000000000000133 · 2013 · External reference

Phosphohistone-H3 proliferation index is superior to mitotic index and MIB-1 expression as a predictor of recurrence in human meningiomas. Am

10.1093/ajcp/aqw141 · 2016 · External reference

MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas

10.1007/s11060-016-2329-0 · 2017 · External reference

Prognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy

10.1371/journal.pone.0097108 · 2014 · External reference

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma

10.1093/neuonc/noab015 · 2021 · External reference

Recurrence of meningiomas: influence of vascular endothelial growth factor expression

10.1002/1097-0142(20000901)89:5<1102::aid-cncr20>3.0.co;2-l · 2000 · External reference

Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy

10.4103/0973-1482.148708 · 2015 · External reference

Programmed death ligand 1 and tumor-infiltrating CD8(+) T lymphocytes are associated with the clinical features in meningioma

10.1186/s12885-022-10249-4 · 2022 · External reference

Analysis of prognostic factors and treatment of anaplastic meningioma in China

10.1016/j.jocn.2014.10.023 · 2015 · External reference

CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018

10.1093/neuonc/noab200 · 2021 · External reference

Diagnostic challenges in meningioma

10.1093/neuonc/nox101 · 2017 · External reference

Epidemiology of intracranial meningioma

10.1227/01.neu.0000188281.91351.b9 · 2005 · External reference

Estrogen and progesterone in meningioma: Bridging the gap of knowledge

10.54029/2023wxj · 2023 · External reference

Progesterone receptor expression in meningiomas: pathological and prognostic implications

10.3389/fonc.2021.611218 · 2021 · External reference

Hormone receptor expression in meningiomas: a systematic review

10.3390/cancers15030980 · 2023 · External reference

New insights into expression of hormonal receptors by meningiomas

10.1016/j.wneu.2020.04.168 · 2020 · External reference

Cyclin A is required at two points in the human cell cycle

10.1002/j.1460-2075.1992.tb05135.x · 1992 · External reference

Cyclin A in cell cycle control and cancer

10.1007/s00018-002-8510-y · 2002 · External reference

Structure and mechanism of DNA topoisomerase II

10.1038/379225a0 · 1996 · External reference

Culprit and victim—DNA topoisomerase II

10.1016/s1470-2045(02)00715-5 · 2002 · External reference

Is p21 an oncogene?

10.1158/1535-7163.mct-06-0163 · 2006 · External reference

Control of cell cycle transcription during G1 and S phases

10.1038/nrm3629 · 2013 · External reference

Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis

2020 · External reference

Eukaryotic MCM proteins: beyond replication initiation

10.1128/mmbr.68.1.109-131.2004 · 2004 · External reference

Overexpression of MCM6 predicts poor survival in patients with glioma

10.1016/j.humpath.2018.04.024 · 2018 · External reference

MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression

2018 · External reference

Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma

10.1007/s00428-017-2278-9 · 2018 · External reference

Regulation of chromatin by histone modifications

10.1038/cr.2011.22 · 2011 · External reference

Histone methylation: dynamic or static?

10.1016/s0092-8674(02)00798-5 · 2002 · External reference

H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis

10.1038/s41467-019-09140-x · 2019 · External reference

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

10.1186/s12885-017-3256-y · 2017 · External reference

Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics

10.1038/modpathol.2015.134 · 2016 · External reference

EZH2 methyltransferase and H3K27 methylation in breast cancer

10.7150/ijbs.8.59 · 2012 · External reference

The emerging relevance of H3K27 trimethylation loss in meningioma: a systematic review of recurrence and overall survival with meta-analysis

10.1016/j.wneu.2022.04.048 · 2022 · External reference

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

10.1038/nrm3722 · 2014 · External reference

Hematologic malignancies: newer strategies to counter the BCL-2 protein

10.1007/s00432-016-2144-1 · 2016 · External reference

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t (14; 18) translocation

10.1016/0092-8674(86)90362-4 · 1986 · External reference

Cloning of the chromosome breakpoint of neoplastic B cells with the t (14; 18) chromosome translocation

10.1126/science.6093263 · 1984 · External reference

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

10.1186/1471-2407-8-153 · 2008 · External reference

Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis

10.1007/s12032-014-0389-6 · 2015 · External reference

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

10.1038/sj.bjc.6601095 · 2003 · External reference

Correlation of Bcl-2 expression with prognosis and survival in patients with head and neck cancer: a systematic review and meta-analysis

10.1016/j.critrevonc.2023.104021 · 2023 · External reference

High expression of Bcl-2 protein predicts favorable outcome in non-small cell lung cancer: evidence from a systematic review and meta-analysis

10.7314/apjcp.2014.15.20.8861 · 2014 · External reference

Surfing the p53 network

10.1038/35042675 · 2000 · External reference

The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis

10.1016/j.clgc.2012.12.009 · 2013 · External reference

Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis

10.1016/j.ejca.2012.03.001 · 2012 · External reference

P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

10.1007/s11060-010-0204-y · 2010 · External reference

Prognostic value of Bcl2 and p53 in Hodgkin lymphoma: a systematic review and meta-analysis

10.1016/j.prp.2021.153370 · 2021 · External reference

VEGF as a key mediator of angiogenesis in cancer

10.1159/000088478 · 2005 · External reference

Cervical cancer—state of the science: from angiogenesis blockade to checkpoint inhibition

10.1016/j.ygyno.2018.01.009 · 2018 · External reference

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

10.1038/sj.bjc.6603176 · 2006 · External reference

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis

10.1158/1078-0432.ccr-04-1870 · 2005 · External reference

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

10.1007/s11033-012-1812-8 · 2012 · External reference

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

10.1038/sj.bjc.6605017 · 2009 · External reference

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis

10.1097/jto.0b013e3181a97e31 · 2009 · External reference

VEGF levels in patients with glioma: a systematic review and meta-analysis

10.1515/revneuro-2020-0062 · 2021 · External reference

Phosphorylated histone H3 (PHH3) as a novel cell proliferation marker and prognosticator for meningeal tumors: a short review

10.1097/pai.0000000000000499 · 2018 · External reference

Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma

10.1038/modpathol.2012.188 · 2013 · External reference

Prognostic value of proliferation in invasive breast cancer: a review

10.1136/jcp.2003.010777 · 2004 · External reference

Molecular mechanisms of the chromosome condensation and decondensation cycle in mammalian cells

10.1002/bies.950050303 · 1986 · External reference

Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells

10.1111/j.1432-1033.1978.tb12135.x · 1978 · External reference

Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis

10.1002/(sici)1097-0320(19980601)32:2<71::aid-cyto1>3.0.co;2-h · 1998 · External reference

Mitotic index and progression-free survival in atypical meningiomas

10.1016/j.wneu.2020.06.189 · 2020 · External reference

Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis

10.1007/s10014-021-00419-w · 2022 · External reference

The Ki‐67 protein: from the known and the unknown

10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · 2000 · External reference

Prognostic role of Ki-67 score in localized prostate cancer: a systematic review and meta-analysis

2017 · External reference

Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis

10.7314/apjcp.2015.16.2.411 · 2015 · External reference

The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases

10.2147/ott.s135593 · 2017 · External reference

Clinicopathological and prognostic value of Ki-67 expression in bladder cancer: a systematic review and meta-analysis

10.1371/journal.pone.0158891 · 2016 · External reference

Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis

10.1038/srep44281 · 2017 · External reference

The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study

10.1016/j.prp.2010.09.002 · 2010 · External reference

Molecular alterations in meningioma: prognostic and therapeutic perspectives

10.1097/cco.0000000000000687 · 2020 · External reference

Discovering the molecular landscape of meningioma: the struggle to find new therapeutic targets

10.3390/diagnostics11101852 · 2021 · External reference

The prognostic significance of TERT promoter mutations in meningioma: A systematic review and meta-analysis

10.1007/s11060-018-03067-x · 2019 · External reference

Human tert promoter mutations in atypical and anaplastic meningiomas

10.3390/diagnostics11091624 · 2021 · External reference

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis

10.1136/jnnp-2019-322257 · 2020 · External reference

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma

10.1093/neuonc/noy104 · 2018 · External reference

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma

10.1007/s11060-019-03333-6 · 2019 · External reference

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

10.1007/s00401-020-02188-w · 2020 · External reference

Unveiling a biomarker signature of meningioma: the need for a panel of genomic, epigenetic, proteomic, and RNA biomarkers to advance diagnosis and prognosis

10.3390/cancers15225339 · 2023 · External reference

Phosphoproteomic and kinomic signature of clinically aggressive grade I (1.5) meningiomas reveals RB1 signaling as a novel mediator and biomarker

10.1158/1078-0432.ccr-18-0641 · 2020 · External reference

A logistic regression model for detecting the presence of malignant progression in atypical meningiomas

10.1016/j.wneu.2019.02.062 · 2019 · External reference